Dermata Therapeutics's total assets for Q1 2024 were $5.18M, a decrease of -35.08% from the previous quarter. DRMA total liabilities were $1.37M for the fiscal quarter, a -15.51% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.